AtriCure Inc ATRC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ATRC is a good fit for your portfolio.
News
-
AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
-
AtriCure to Announce Second Quarter 2024 Financial Results
-
AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
-
AtriCure Reports First Quarter 2024 Financial Results
-
AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
Trading Information
- Previous Close Price
- $23.53
- Day Range
- $22.00–24.10
- 52-Week Range
- $18.94–58.00
- Bid/Ask
- $21.95 / $23.62
- Market Cap
- $1.07 Bil
- Volume/Avg
- 693,923 / 873,067
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.48
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.69%
Company Profile
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,200
- Website
- https://www.atricure.com
Comparables
Valuation
Metric
|
ATRC
|
MMSI
|
ZIMV
|
---|---|---|---|
Price/Earnings (Normalized) | — | 27.25 | 24.57 |
Price/Book Value | 2.34 | 4.01 | 1.52 |
Price/Sales | 2.48 | 3.90 | 1.06 |
Price/Cash Flow | 53.12 | 21.91 | 24.11 |
Price/Earnings
ATRC
MMSI
ZIMV
Financial Strength
Metric
|
ATRC
|
MMSI
|
ZIMV
|
---|---|---|---|
Quick Ratio | 2.63 | 4.22 | 0.66 |
Current Ratio | 4.00 | 6.03 | 2.68 |
Interest Coverage | −4.80 | 6.17 | −1.06 |
Quick Ratio
ATRC
MMSI
ZIMV
Profitability
Metric
|
ATRC
|
MMSI
|
ZIMV
|
---|---|---|---|
Return on Assets (Normalized) | −6.08% | 9.17% | −0.10% |
Return on Equity (Normalized) | −7.88% | 15.14% | −0.24% |
Return on Invested Capital (Normalized) | −6.35% | 10.93% | 0.96% |
Return on Assets
ATRC
MMSI
ZIMV
Medical Instruments & Supplies Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Intuitive Surgical Inc
ISRG
| Mbjfzycjgs | Ddmg | $156.8 Bil | |||
Becton Dickinson & Co
BDX
| Xmywdflc | Bnzlxj | $68.6 Bil | |||
Alcon Inc
ALC
| Lqcqpfq | Dmlrmh | $46.5 Bil | |||
Coloplast A/S ADR
CLPBY
| Tfxmcwpxcj | Zvxxf | $29.1 Bil | |||
ResMed Inc
RMD
| Fsjrvgxjw | Tzkdltg | $28.9 Bil | |||
West Pharmaceutical Services Inc
WST
| Vxmckjvqyx | Vtsf | $20.7 Bil | |||
The Cooper Companies Inc
COO
| Qgrtrykl | Rhwbn | $18.6 Bil | |||
Hologic Inc
HOLX
| Sxlrjkwm | Tptqxv | $18.4 Bil | |||
Baxter International Inc
BAX
| Qxgwzcdd | Xwypfv | $18.1 Bil | |||
Teleflex Inc
TFX
| Htqmm | Tnr | $10.4 Bil |